chrisvoncsefalvay/vaers-outcomes huggingface dataset:
HIGH BLOOD SUGAR; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: non smoker, and non alcohol user, and other pre-existing medical conditions included: The patient had a allergy to pain medication (vomiting). The patients blood sugar level was 5.2 and weight was great before vaccination. The patient was previously treated with covid-19 vaccine ad26. cov2 (dose number in series 1) (suspension for injection, route of admin not reported, batch number: OH3A214 expiry: UNKNOWN), dose was not reported, 1 total administered on 09-APR-2021 for covid-19 prophylaxis (dose number in series 1). No adverse events reported following vaccination (dose number in series 1). The patient additionally received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855191 expiry: UNKNOWN) dose was not reported,1 total administered on 05-DEC-2021 to left Arm for covid-19 prophylaxis. Concomitant medications included metformin for drug used for unknown indication.  On an unspecified date, the patients blood sugar level increased 6.9 (Dose number in series 2). The patient doctor gave Ozempic for treatment. After stopped taking Ozempic patients blood sugar level again increased. The patient stated that after taking two medications blood sugar level was only 6.2. The patient took Jardiance and had horrible side effects, gave her E.coli (Escherichia). The patient-maintained sugar level by eating 30 carbs per meal. The patient visited gynecologist. The patient was upset because doing everything still side effect are same. Laboratory data (dates unspecified) included: Blood sugar increased 6.9, 6.2. Treatment medications (dates unspecified) included: semaglutide, and empagliflozin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from high blood sugar. This report was non-serious. This case, from the same reporter is linked to 20231105443.
Greater than typical pain during the injection.  Felt the injection was too high on the arm at the time of the injection.  Next morning intense pain in the left should joint.  Pain radiates down the arm to the top of the hand.  Increased pain with movement of the shoulder.  Today is day 11 post flu vaccine administration and there is no improvement in the left shoulder and arm pain.
On August 18th I experienced significant swelling, irritation and pain in both my lips.  I have experienced this prior when I recieved the 3rd dose of the gardisil vaccine.  My lips were red, swollen, and painful.  They also looked as if they had a small rash on them.  This lasted for approximately 24 hours.  However,  I use a topical lip treatment daily to help with irritation.
Had varicella injection on 5/6/97. Broke out with chickenpox on 9/17/00. Came to office on 9/18/00 and was dx'd with chickenpox. Presently has chickenpox.
feels like if someone is chopping her arm off; Patient partially blames the lack of efficacy on poor administration by the pharmacist; feels like if someone is chopping her arm off, wose than child birth; continuous stabbing pain at the injection site/Left arm painful after second shot; This spontaneous case was reported by a pharmacist and describes the occurrence of FEELING ABNORMAL (feels like if someone is chopping her arm off), PRODUCT ADMINISTRATION ERROR (Patient partially blames the lack of efficacy on poor administration by the pharmacist), PAIN (feels like if someone is chopping her arm off, wose than child birth) and VACCINATION SITE PAIN (continuous stabbing pain at the injection site/Left arm painful after second shot) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced FEELING ABNORMAL (feels like if someone is chopping her arm off), PRODUCT ADMINISTRATION ERROR (Patient partially blames the lack of efficacy on poor administration by the pharmacist), PAIN (feels like if someone is chopping her arm off, wose than child birth) and VACCINATION SITE PAIN (continuous stabbing pain at the injection site/Left arm painful after second shot). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency and OXYCODONE for Adverse event, at an unspecified dose and frequency. On 05-Apr-2021, PRODUCT ADMINISTRATION ERROR (Patient partially blames the lack of efficacy on poor administration by the pharmacist) had resolved. At the time of the report, FEELING ABNORMAL (feels like if someone is chopping her arm off), PAIN (feels like if someone is chopping her arm off, wose than child birth) and VACCINATION SITE PAIN (continuous stabbing pain at the injection site/Left arm painful after second shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reported that she felt pain in waves, worse than child birth. She could not use her arm. On 21-Apr-2021, antibody test to Covid-19 came back negative. The patient treated the symptoms with ice pack.   This case was linked to MOD-2021-100703 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Reporter details, product information and relevant test updated.
pt recvd vax & was irritable & crying fits; limp; quiet; pale & apneic;
more than 12 hours after the first puncture; 27 hours at room temperature; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (more than 12 hours after the first puncture) and PRODUCT STORAGE ERROR (27 hours at room temperature) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00J21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (more than 12 hours after the first puncture) and PRODUCT STORAGE ERROR (27 hours at room temperature). At the time of the report, EXPIRED PRODUCT ADMINISTERED (more than 12 hours after the first puncture) and PRODUCT STORAGE ERROR (27 hours at room temperature) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. No treatment medication reported by reporter.   This case was linked to MOD-2022-494555, MOD-2022-494521 (Patient Link).
Noticed tinnitus approx 3 days after receiving 1st Moderna COVID19 vaccination.  Ringing is constant, but volume level varies; seems predominantly in right ear.  This has continued daily, no signs of abating as of today.  No past history of any incidents of tinnitus.
Slight headache on waking.  Muscle soreness.  General malaise.  As morning progressed developed a headache like a migraine.  Did not feel like blood pressure was elevated but took anyway.  BP was 171/110.  Remained in that range through afternoon. Called and reported to my doctor all symptoms.  Told to rest.  I took Tylenol 650 mgs which helped relieve the headache.  BP down to 140/90 at night.  By 9am BP was normal 123/82.  I do not take BP medicine.  I constantly monitor BP so found this to be unusual. Still have slight headache and body aches.
Itching and injection site redness reported. Treated with Children's Benadryl.
ARM PAIN, COVID INFECTION Narrative: 2/16/2021: Having right upper arm and neck pain. Throbbing pain in certain positions. No weakness or numbness in my arm. 2/18/2021: presented to ED with no redness or swelling but with palpable "pea-size" knot at the injection site, d/c with lidociane/prilocaine cream and diclofenac gel. advised to take tylenol prm. 3/17/2021: exposed to Covid from son and c/o body aches, runny nose, pain in back 3/18/2021: tested positive for covid 3/25/2021: most symptoms resolved, self-treated at home
6hrs p/vax pt exp heaviness of breathing, redness of area of site, generalized rash over entire body.
Developed myalgia from injection within 6 hrs. However, after 2 weeks, myalgia is still present in left arm and right arm. I also have arthralgia in left/right shoulder, right elbow, right wrist, and right knuckles. I do not have arthritis. Or, I didn't have it before vaccine. I mean heck, I'm 53 so maybe this just popped up after the vaccinations. But the muscle weakness in my arms is really different. If symptoms do not go away by may, I will goto the clinic to get evaluated.
On May 27th, I had an episode of double vision and light headedness and my blood pressure was up. Not quite confusion but just strange. They thought it might be a mini stroke - so I had an MRI or MRA - showed vascular changes but showed no acute stroke and carotids were okay. Also  did an EKG with some changes and a repeat  EKG - and that one seemed like a normal EKG.  I  had an echocardiogram - on Tuesday; Coronary CT on Wednesday and radiologist called my primary care doctor  and said there was a "broken glass" opaqueness (opacity) of left upper lobe. This Wednesday with the chest x-ray, I'm concerned - I have been short of breath and tired lately - just not feeling good. On May 28th,  I started Lisinopril for blood pressure and also started aspirin.  My blood pressure is still fluctuating.  I'm waiting for a lung CT to be scheduled - Pulmonary function study to be schedule and that's a couple of weeks out.  I haven't had another episode of double vision.  Fatigue and short of breath and I have had some diarrhea. I had had some weird GI stuff all winter long but it restarted (diarrhea) 2 weeks ago. I hadn't had it for four months or so.
Swollen lymph node under right arm quickly following the vaccine.  Within a week - Other swollen lymph nodes, numbness and tingling in left toes, foot, hand, and face.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Severe, Additional Details: pt fainted for a couple of seconds, after 15 minutes \"wasn't feeling well\" 911 was notified and he was brought to the emergency room
Recipient was given a Pfizer vaccine instead of the Moderna vaccine which he had as the first dose.
allergy to Influenza Virus Vaccine Whole; Drug Allergies (Dronedarone and Lovastatin); Initial information received on 04-Sep-2020 regarding an unsolicited valid non-serious case received from a physician (via non-licensed Pfizer company).  This case involves a patient (age and gender not reported) who experienced allergy to influenza virus vaccine whole and drug allergies while he/she received INFLUENZA VACCINE and while treated with DRONEDARONE and LOVASTATIN.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not known.   On an unknown date, the patient started taking DRONEDARONE dosage unknown (with an unknown batch number, other dosing details not reported) and LOVASTATIN dosage unknown (with an unknown batch number, other dosing details not reported) for unknown indication. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious allergy to influenza virus vaccine whole (allergy to vaccine) (Unknown latency) following vaccination. On an unknown date, the patient developed a non-serious drug allergies (drug hypersensitivity) (Unknown latency) following administration of DRONEDARONE and LOVASTATIN. Other case details: It was reported that the patient had allergies to Dronedarone, Influenza Virus Vaccine Whole, Lovastatin and Sulfa (Sulfonamide antibiotics). It was also reported that the patient had a prescription of Pregabalin (Lyrica) 50 mg capsule and was taking Neurontin (not reported before or after administration of suspect products).  No relevant tests were reported.  Action taken for DRONEDARONE (DRONEDARONE) and LOVASTATIN (LOVASTATIN) was unknown.  It was not reported if the patient received a corrective treatment.  The outcome for events was unknown at the time of report.
Sixteen hours post dose 2 of SHINGRIX, I experienced SOB, feeling of pins and needles, and in some areas of my lungs nail-like sensations. I also experienced chest tightness. Believing at first that I may have been dehydrated due to the nature of my scleroderma, I drank almost a liter of water which I take with me bedside at night. This was at 0230. The pain intensified as I drank water but subsided somewhat in about 30 minutes, which decreased to about 7 on a scale of 1-10. I keep an albuterol inhaler in my nightstand and used 2 puffs every two hours. If the pain had intensified my plan was to have my husband take me to the ER or call for help, whichever was relative to my condition at the time. I did not sleep much between the outset of the event and 600 am when I got up and ate a small amount of cereal. I started to feel better in terms of breathing, still experiencing the sensation of pins, needles, and nails in my lungs. I felt well enough to attend a final physical therapy session for an ankle fracture, but was unable to complete the session due to SOB, weakness, hypotension with sweating. I was unable to drive; my husband drove me to and from the clinic. From 0800 this same day, I rested either sitting up or sleeping in bed. Around late afternoon I started to improve, pain down to 4-5 and able to swallow without pain. I am also a pharmacist. Believing it was not the vaccine at first because I did not have any reaction to dose 1 of SHINGRIX, I did not review any literature. But reviewing the package insert, contacting GSK this morning, I believe this may be the vaccine adjuvant. I am sensitive to certain plants and molds.
This spontaneous report was received from an office manager and refers to a female patient of unknown age. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On an unknown date, the patient was vaccinated with the first dose of GARDASIL 9 injection via intramuscular route (dose, lot number and expiration date were not reported) as an human papillomavirus (HPV) prevention. On 24-APR-2018, the patient was diagnosed with mononucleosis. The outcome of the event was unknown. The relatedness between the event and GARDASIL 9 was not reported.
Site tender evening of 5/15/ hard knot and swelling 5/16. Pain from thumb joint up arm to base of skull 5/17. Site continued to get extremely sore and hard. Continued to 5/18 couldn't raise arm. Awoke middle of night 5/18 with intense headache. Vomiting early morning 5/19. 5/23 burning pain under armpit with rash on torso. By 5/24 improvement with return of mobility, decreased swelling, no rash or headache.
2nd dose- from 700pm on 2/1/2021 to 4pm on 2/2/2021- I had severe muscle and bone aches in my hips/ legs/ feet, fever up to 101.4, chills, severe headache and neck pain, eye pain, fatigue.  i had on and off again nausea. I did have a sore arm  for the next 4 days. I took 400- 800mg Ibuprofen around the clock  from 7pm on 2/1/ 2021 to 1230 on 2/21/2021 and switched to 1000mg of tylenol  on 2/2/2021 T 9PM.   1st dose- I had sore arm  for about 4 days and 4 headaches in one week. I was also tired on and off for the next five days.
This spontaneous report as received from a medical assistant via a company representative refers to an 11-year-old male patient with Horner's syndrome. On the following dates: 04-SEP-2014, 05-JAN-2015, and 29-APR-2015, the patient received all three doses of GARDASIL injection, administered intramuscularly in the left arm (strength, dose, lot# and expiry date unspecified for all). It was also stated that the patient received his 2nd and 3rd doses at 5 and 8 months after the 1st dose, which was other-than-indicated in the Prescribing information. Concomitant therapies included meningococcal vaccine (unspecified) and FLUMIST and T-DAT. On 04-SEP-2014, the patient fainted 8 times after receiving the 1st dose of GARDASIL. The patient sought unspecified medical attention. No treatment was given and no laboratory tests were performed. Therapy with GARDASIL was continued. The outcome of the event was unknown. The relatedness between the event and GARDASIL was not reported. Additional information has been requested.
swelling at the injection site, size of baseball; Injection site was hard; redness at the injection site; pain at injection site; Headache; Malaise; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix with an associated reaction of injection site erythema (1st dose received on 11th January 2022 and had injection site redness, pain, headache and malaise, for tolerance refer case US2022AMR046709).   On 11th March 2022, the patient received the 2nd dose of Shingrix. On 12th March 2022, 1 days after receiving Shingrix, the patient experienced injection site swelling, injection site induration, injection site erythema, injection site pain, headache and malaise. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site swelling, injection site induration, injection site erythema, injection site pain, headache and malaise were not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling, injection site induration, injection site erythema, injection site pain, headache and malaise to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR046709  Additional details were provided as follows: The patient self-reported this case. The patient received 2nd dose of Shingrix vaccine and second day after vaccination she experienced swelling at the injection site which grew to be the size of a baseball and was hard, redness at the injection site, pain at injection site, headache and malaise. The patient stated that the above side effects had not gone away.  Referred patient to HCP (health care professional) and provided medical advise disclaimer. Offered PI (package insert). The reporter consented to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR046709:Same patient, different dose
Severe Soreness in Right arm above site of injection and formed a bump.  Patient complains this occurred 2 days after receiving vaccine, and pain is unbearable between shoulder and neck with bump formation between the two points.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 14-JUL-2016, the patient was administered subcutaneously with a 0.5 ml dose of VARIVAX (lot # reported as L050561, expiration date: 14-DEC-2017) during the temperature excursion. No adverse effects were reported. Product quality complaint was not involved. This is one of the two reports received from the same reporter. Additional information has been requested.
Immediately post vax, the pt developed an injection site reaction characterized by a red, itchy, welt, described as a target. Blood pressure was increased to 132/100. The pt was treated with diphenhydramine and recovered.
it knocked her out for a day.; This case was reported by a consumer via call center representative and described the occurrence of loss of consciousness in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced loss of consciousness (serious criteria GSK medically significant). On an unknown date, the outcome of the loss of consciousness was recovered/resolved.   It was unknown if the reporter considered the loss of consciousness to be related to Shingrix.  Additional case details were reported as follows: The reporter was patient's friend. The patient received a dose of Shingrix and reported it knocked her out for a day. The reporter did not have any additional information to provide about the event or the patient. The reporter did not consent to follow up
high fever;severe pain, redness & swelling of leg;unable to walk for several days;
Headache Narrative: Headache; has hx of migraines; self resolved in 48 hours.
Warm, raised, red softball-sized area on the upper arm where vaccination was given. Patient reported the reaction appeared yesterday.
Received a seasonal flu shot. The next morning I woke up and couldn't stand or walk due to severe dizziness, weakness and extreme fatigue. Intermittent headaches. The symptoms have persisted and although they seem to be improving they are not going away.
I started waking up with a stiff neck. My shoulders and hips were also stiff. It hurt to sit even in a wooden chair in my closet. It was so bad, it took both hands to get up out of bed. I contacted the doctor, and she changed one of my prescriptions to muscle relaxers, which still didn't work. She later diagnosed me Polymyalgia after running a few test. I began to feel much better after she gave me Prednisone to take.
arm feels a bit numb-like; change in voice; cough; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), PAIN IN EXTREMITY (sore arm), HYPOAESTHESIA (arm feels a bit numb-like) and DYSPHONIA (change in voice) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced COUGH (cough) and PAIN IN EXTREMITY (sore arm). On 31-Mar-2021, the patient experienced HYPOAESTHESIA (arm feels a bit numb-like) and DYSPHONIA (change in voice). At the time of the report, COUGH (cough), PAIN IN EXTREMITY (sore arm), HYPOAESTHESIA (arm feels a bit numb-like) and DYSPHONIA (change in voice) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medications were  provided by Reporter. No Treatment Medications were  provided by Reporter.
Chills, body and joint aches, fever up to 101.1 appeared 12 hours after injection, lasted about 32-36 hours. Soreness and aches at injection site for about 72 hours after injection. Large red patch and severe itching around injection site, appeared about day 4 after injection, lasted less than 24 hours.
Fatigue; This is a spontaneous report received from a contactable reporter (Nurse). A 75-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date Feb2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 28Feb2021, outcome "recovered", described as "Fatigue". Therapeutic measures were not taken as a result of fatigue.  No follow-up attempts are possible. No further information is expected.